Figure 4.

Neutral C^N-chelating half-sandwich Ir(III)Cp* complexes and monodentate N-coordinated analogues, with in vitro antimalarial activity targeting hemozoin inhibition and the NAD⁺/NADH cycle, by intracellular catalysis [29].